MorphoSys Research Site

Vitoria-Gasteiz 01009

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma

Studies at this site

• Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients — Running, not enrolling
• Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL — Completed